0
Articles |

Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I FREE TO VIEW

Anne E. O'Donnell; Alan F. Barker; Jonathan S. Ilowite; Robert B. Fick; rhDNase Study Group
Author and Funding Information

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.


Affiliations: From the Divisions of Pulmonary and Critical Care Medicine, Georgetown University Medical Center, Washington, DC,  From the Oregon Health Sciences University, Portland,  From the Winthrop University Hospital, Mineola, NY,  From the Genentech, Inc, South San Francisco, Calif.

1998 by the American College of Chest Physicians


Chest. 1998;113(5):1329-1334. doi:10.1378/chest.113.5.1329
Text Size: A A A
Published online

Abstract

Study objective: To study the safety and efficacy of aerosolized recombinant human DNase I in the treatment of idiopathic bronchiectasis.

Design: Double-blind, randomized, placebo-controlled, multicenter study.

Populations: Three hundred forty-nine adult outpatients in stable condition with idiopathic bronchiectasis from 23 centers in North America, Great Britain, and Ireland.

Interventions and measurements: Study patients received aerosolized rhDNase or placebo twice daily for 24 weeks. Primary end points were incidence of pulmonary exacerbations and mean percent change in FEV1 from baseline over the treatment period.

Results: Pulmonary exacerbations were more frequent and FEV1 decline was greater in patients who received rhDNase compared with placebo during this 24-week trial.

Conclusions: rhDNase was ineffective and potentially harmful in this group of adult outpatients in stable condition with idiopathic bronchiectasis. This contrasts with previously published results that demonstrated efficacy of rhDNase in patients with cystic fibrosis bronchiectasis.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Pulmonary complications of cystic fibrosis. Respir Care 2009;54(5):618-27.
[Cystic fibrosis in adults]. Rev Port Pneumol 2007 May-Jun;13(3):335-47.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543